Permanently Discontinued

SUSTIVA 200MG

BRISTOL-MYERS SQUIBB CANADA

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is SUSTIVA 200MG discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that SUSTIVA 200MG has been permanently discontinued (last updated April 1, 2023). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is SUSTIVA 200MG not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Check with your pharmacist — only products with a different form or route found

StatusPermanently Discontinued

Same-ingredient products on file1 product · 0 same form & route

Affected strength200MG

Report last updated2023-04-01

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

AURO-EFAVIRENZ

AURO PHARMA INC

600MG · DIN 02418428

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02239888

Strength

200MG

Dosage Form

CAPSULE

Route

ORAL

Active Ingredient

EFAVIRENZ

Tier

Unrated

Last Updated

2023-04-01

Reason for Shortage

Business reasons

Source

View original report on healthproductshortages.ca ↗

Other Products from BRISTOL-MYERS SQUIBB CANADA

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ABRAXANE FOR INJECTABLE SUSPENSION

100MG · DIN 02281066

BARACLUDE

0.5MG · DIN 02282224

BREYANZI

120000000CELLS · DIN 02527138

CAMZYOS

10MG · DIN 02532565

CAMZYOS

2.5MG · DIN 02532549

CAMZYOS

15MG · DIN 02532573